Management of breast ductal carcinoma in situ in Catalonia, Spain: Results from the Grup Oncologic Calalà-Occità-Catalonia survey with 9-year follow up-Reference-Cited by-同舟云学术

Management of breast ductal carcinoma in situ in Catalonia, Spain: Results from the Grup Oncologic Calalà-Occità-Catalonia survey with 9-year follow up

Published:2017-10 Issue: Volume:35 Page:196-202
ISSN:0960-9776
Container-title:The Breast
language:en
Short-container-title:The Breast

Author:

Cambra M.J.,Farrús B.,Moreno F.,Anglada Ll,Arenas M.,Ballester R.,Casals J.,Cusidó M.,García V.,Gutiérrez C.,Mollà M.,Pedro A.,Reyes V.,Sanz X.

Funder

ASTRA ZENECA

Publisher

Elsevier BV

Subject

General Medicine,Surgery

Reference52 articles.

1. Textbook of surgery. The biological basis of modern surgical practice;Grace;Br J Surg,1997

2. Heterogeneity of ductal carcinoma in situ and its effects on management;Mokbel;Lancet Oncol,2006

3. Trends in the treatment of ductal carcinoma in situ of the breast;Baxter;JNCI J Natl Cancer Inst,2004

4. The management of ductal carcinoma in situ in North America and Europe;Ceilley;Cancer,2004

5. Ductal carcinoma in situ of the breast, a population-based study of epidemiology and pathology;Kricker;Br J Cancer,2004

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Readmissions and complications in breast ductal carcinoma in situ: A retrospective study comparing screen- and non-screen-detected patients;Women's Health;2020-01

2. Les carcinomes canalaires in situ en 2019 : diagnostic, traitement, pronostic;La Presse Médicale;2019-10

3. Role of boost radiotherapy for local control of pure ductal carcinoma in situ after breast-conserving surgery: a multicenter, retrospective study of 622 patients;Clinical and Translational Oncology;2019-07-01

4. Stromal characteristics are adequate prognosticators for recurrence risk in ductal carcinoma in situ of the breast;European Journal of Surgical Oncology;2019-04

5. Mortality of women with ductal carcinoma in situ of the breast: a population-based study from the Girona province, Spain (1994–2013);Clinical and Translational Oncology;2018-12-10